Journey Medical (DERM)
(Delayed Data from NSDQ)
$5.46 USD
0.00 (0.00%)
Updated Jul 22, 2024 01:08 PM ET
3-Hold of 5 3
C Value D Growth B Momentum D VGM
Cash flow Statements
Fiscal Year End for Journey Medical Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -3.85 | -29.63 | -43.99 | 5.28 | 3.63 |
Depreciation/Amortization & Depletion | 7.35 | 4.43 | 5.13 | 1.52 | 1.26 |
Net Change from Assets/Liabilities | -1.66 | 6.19 | 14.71 | -2.23 | 3.47 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 3.39 | 5.48 | 21.97 | 0.56 | 0.66 |
Net Cash From Operating Activities | 5.24 | -13.53 | -2.18 | 5.13 | 9.02 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -5.00 | -20.00 | -10.00 | -1.20 | -2.40 |
Net Cash from Investing Activities | -5.00 | -20.00 | -10.00 | -1.20 | -2.40 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 4.62 | 0.14 | 51.51 | 0.01 | 0.00 |
Issuance (Repayment) of Debt | -6.00 | 14.76 | -5.30 | -0.50 | 0.00 |
Increase (Decrease) Short-Term Debt | -2.95 | 2.14 | 10.35 | 0.00 | -3.55 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.47 | -0.59 | -3.55 | 0.00 | 0.00 |
Net Cash from Financing Activities | -4.80 | 16.46 | 53.02 | -0.49 | -3.55 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -4.56 | -17.08 | 40.84 | 3.45 | 3.07 |
Cash at Beginning of Period | 32.00 | 49.08 | 8.25 | 4.80 | 1.73 |
Cash at End of Period | 27.44 | 32.00 | 49.08 | 8.25 | 4.80 |
Diluted Net EPS | -0.21 | -1.69 | -4.32 | 0.49 | NA |
Fiscal Year End for Journey Medical Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -10.44 | -3.85 | -1.71 | -18.50 |
Depreciation/Amortization & Depletion | NA | 0.90 | 7.35 | 6.51 | 5.62 |
Net Change from Assets/Liabilities | NA | 3.11 | -1.66 | 14.03 | 13.62 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 1.41 | 3.39 | 2.92 | 2.27 |
Net Cash From Operating Activities | NA | -5.02 | 5.24 | 21.76 | 3.01 |
Property & Equipment | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | -5.00 | -5.00 | -5.00 |
Net Cash from Investing Activities | NA | 0.00 | -5.00 | -5.00 | -5.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 1.64 | 4.62 | 0.03 | 0.00 |
Issuance (Repayment) of Debt | NA | 0.00 | -6.00 | -21.00 | -10.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | -2.95 | -2.95 | -2.95 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | -0.47 | -0.09 | -0.09 |
Net Cash from Financing Activities | NA | 1.64 | -4.80 | -24.01 | -13.04 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -3.38 | -4.56 | -7.25 | -15.02 |
Cash at Beginning of Period | NA | 27.44 | 32.00 | 32.00 | 32.00 |
Cash at End of Period | NA | 24.06 | 27.44 | 24.75 | 16.98 |
Diluted Net EPS | NA | -0.53 | 0.02 | 0.80 | -0.46 |